Jan Schjøtt
Impact in
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 5%
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 6
-
- Pregnancy and Medication Impact 8
- Co-authors
- Tormod Bjånes (8 shared papers)Emmet McCormack (4 shared papers)Spiros Kotopoulis (4 shared papers)Bjørn Tore Gjertsen (3 shared papers)Odd Helge Gilja (4 shared papers)Georg Dimcevski (2 shared papers)Halfdan Sørbye (2 shared papers)Anders Molven (2 shared papers)
In The Last Decade
Jan Schjøtt
83 papers receiving 1.3k citations
Jan Schjøtt's Hit Papers
Peers
Comparison fields: 5 of 124
- Geriatrics and Gerontology 109
- Family Practice 38
- Toxicology 43
- Applied Microbiology and Biotechnology 15
- Biomedical Engineering 349
Countries citing papers authored by Jan Schjøtt
This map shows the geographic impact of Jan Schjøtt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Schjøtt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Schjøtt more than expected).
Fields of papers citing papers by Jan Schjøtt
This network shows the impact of papers produced by Jan Schjøtt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Schjøtt. The network helps show where Jan Schjøtt may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Schjøtt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer Hit paper breakdown → | 2016 | 365 |
| 2 | 2016 | 50 | |
| 3 | 2003 | 38 | |
| 4 | 2018 | 37 | |
| 5 | 2010 | 32 | |
| 6 | 2008 | 32 | |
| 7 | 2016 | 26 | |
| 8 | 2013 | 26 | |
| 9 | 2012 | 26 | |
| 10 | 2012 | 25 | |
| 11 | 2001 | 24 | |
| 12 | 2019 | 23 | |
| 13 | 2010 | 23 | |
| 14 | 2020 | 22 | |
| 15 | 2020 | 22 | |
| 16 | 2016 | 21 | |
| 17 | 2015 | 20 | |
| 18 | 2001 | 20 | |
| 19 | 2001 | 20 | |
| 20 | 2012 | 19 |
About Jan Schjøtt
Jan Schjøtt is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Molecular Biology, having authored 92 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pregnancy and Medication Impact (8 papers), Pharmaceutical Practices and Patient Outcomes (8 papers), Pharmaceutical Economics and Policy (6 papers), Pharmaceutical studies and practices (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Cardiac Ischemia and Reperfusion (6 papers), Medication Adherence and Compliance (4 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). The work is most often cited by research in Geriatrics and Gerontology (109 citations), Family Practice (38 citations), Toxicology (43 citations), Applied Microbiology and Biotechnology (15 citations) and Biomedical Engineering (349 citations). Jan Schjøtt has collaborated with scholars based in Norway, Sweden and Denmark. Frequent co-authors include Tormod Bjånes, Emmet McCormack, Spiros Kotopoulis, Bjørn Tore Gjertsen, Odd Helge Gilja, Georg Dimcevski, Halfdan Sørbye, Anders Molven, Dag Hoem and Martin Biermann. Their work appears in journals such as European Journal of Clinical Pharmacology, Clinical Therapeutics, Basic & Clinical Pharmacology & Toxicology, Pharmaceutics and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.